Prognostic value of cyclin E expression in breast cancer: a meta-analysis (Q45751455)

15 December 2017

meta-analysis

0 references

title

Prognostic value of cyclin E expression in breast cancer: a meta-analysis (English)

1 reference

15 December 2017

author name string

Sheng Gao

series ordinal

1

1 reference

15 December 2017

Jing-Jing Ma

series ordinal

2

1 reference

15 December 2017

Cheng Lu

series ordinal

3

1 reference

15 December 2017

publication date

18 June 2013

1 reference

15 December 2017

published in

Tumor Biology

1 reference

15 December 2017

volume

34

1 reference

15 December 2017

issue

6

1 reference

15 December 2017

page(s)

3423-3430

1 reference

15 December 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Changes to adjuvant systemic therapy in breast cancer: a decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Prognostic and predictive factors revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

21 January 2018

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Regulation of the mammalian cell cycle: a model of the G1-to-S transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Deregulation of cyclin E in human cells interferes with prereplication complex assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Cyclin e overexpression reduces infiltrative growth in breast cancer: yet another link between proliferation control and tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Systematic reviews of evaluations of prognostic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Cyclin E and survival in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Impact of cyclins E, neutrophil elastase and proteinase 3 expression levels on clinical outcome in primary breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

To cycle or not to cycle: a critical decision in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0915-8

Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer

21 January 2018

1 reference

12 December 2020

Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

1 reference

12 December 2020

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

12 December 2020

Cyclin E immunoexpression in breast ductal carcinoma: pathologic correlations and prognostic implications

1 reference

12 December 2020

Cyclin E expression in operable breast cancer quantified using real-time RT-PCR: a comparative study with immunostaining

1 reference

12 December 2020

Prognostic relevance of cyclin E expression in operable breast cancer

1 reference

12 December 2020

The role of cyclin E in the regulation of entry into S phase

1 reference

12 December 2020

Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer

1 reference

12 December 2020

Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients

1 reference

12 December 2020

10.1007/S13277-013-0915-8

Identifiers

DOI

1 reference

15 December 2017

Dimensions Publication ID

1024715037

0 references

1 reference

15 December 2017